Sanjana Mehrotra, MD
- MBBS; Topiwala National Medical College, Mumbai, India (2001)
- AP/CP Residency; Baystate Regional Medical Center/Tufts University, Springfield, MA (2011)
- Transfusion Medicine Fellowship, University of Colorado Denver (2012)
- Cytology Fellowship, University of Colorado Denver (2013)
- Surgical Pathology Fellowship
- Research Fellow, Indiana University Purdue University, Indianapolis, IN, (2003–2005)
- NIH granted project: Retrospective analysis by immunohistochemistry of various cyclooxygenase and prostaglandin receptors in breast cancer; VEGF, CD31 study; Optimization of NF-kappa B immunohistochemical stain in mice tissue with injected cell lines.
- Thorat MA, Morimiya A, Mehtrotra S, Konger A, Badve S. Prostanoid EP1 receptor in breast cancer. Modern Pathology. 2008 January; 21(1): 15-21.
- Thorat MA, Morimiya A, Mehrotra S, Badve S. COX-2 expression does not correlate with microvessel density in breast cancer. Pathobiology. 2009; 76(1): 39-44.
- Blanchet GV, Allen HF, Mehrotra SP, Richardson MW. The tumor lysis syndrome in a child with multicentric Castleman disease. Journal of Pediatric Hematologic Oncology. 2010 April; 32(3): 247-9.